Neumora Therapeutics, Inc. (NMRA)

Last Three Months

04-Feb-24 -- 03-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Accumulate

Insider Trading Sentiment: Accumulate

Insider Trading Sentiment: Accumulate

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

6

0

6

+1

0

+2

0

+3

Two Year Chart

04-May-22 -- 03-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Feb-24 4:21 PM View:	14-Feb-24 Grant 0	Pinto Joshua Chief Financial Officer		Neumora Therapeutics, Inc. - NMRA	36% 238.97K to 323.96K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 4:15 PM View:	14-Feb-24 Grant 0	Gosebruch Henry O President & CEO Director		Neumora Therapeutics, Inc. - NMRA	15% 524.79K to 604.79K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 4:19 PM View:	14-Feb-24 Grant 0	Suh Carol Y. Chief Operating Officer		Neumora Therapeutics, Inc. - NMRA	29% 289.67K to 374.67K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 4:13 PM View:	14-Feb-24 Grant 0	Lenz Robert A. Head of R&D		Neumora Therapeutics, Inc. - NMRA	14% 352.94K to 402.94K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 4:14 PM View:	14-Feb-24 Grant 0	Milligan Michael Lee See Remarks		Neumora Therapeutics, Inc. - NMRA	539% 3.82K to 24.45K	0	0	--	--	Show Txns Hide Txns

16-Feb-24 4:17 PM View:	14-Feb-24 Grant 0	Berns Paul L Director		Neumora Therapeutics, Inc. - NMRA	2% 7.65M to 7.82M	0	0	--	--	Show Txns Hide Txns

24-Apr-24 5:00 PM View:	22-Apr-24 Gift 0	Aurora Daljit Singh Chief Strategy Officer		Neumora Therapeutics, Inc. - NMRA	85% 114.7K to 212.2K	0	0	--	--	Show Txns Hide Txns